SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001078782-12-001161
Filing Date
2012-04-30
Accepted
2012-04-30 12:37:48
Documents
3
Group Members
DERMASTAR INTERNATIONAL, LLCMARK L. BAUMROBERT KAMMER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f13d042712_sc13d.htm SC 13D 71015
2 EXHIBIT 1 JOINT FILING AGREEMENT f13d042712_ex1.htm EX-1 3966
3 EXHIBIT 2 WAIVER AGREEMENT f13d042712_ex2.htm EX-2 20748
  Complete submission text file 0001078782-12-001161.txt   97295
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83793 | Film No.: 12793424
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Filed by) CIK: 0001542484 (see all company filings)

Type: SC 13D